The analysis reveals that genomics has seen explosive growth in clinical research over the past decade, with over 6,500 studies registered globally.
As genomic medicine evolves, health systems are embedding pharmacogenomics into pharmacy operations, not only as a research function but as a clinical asset to personalize patient treatment and reduce ...
Researchers from Nazarbayev University's National Laboratory created the first large-scale, high-quality genotyping dataset ...
WHO reports under 5% of genomic studies focus on low and middle-income countries, urging action for health equity and ...
The ‘Genomic Era’ holds great promise for improving health of individuals and families. Unfortunately advances in genomic healthcare have not benefited all populations equally. To realize the full ...
A recent World Health Organization (WHO) analysis reveals that less than 5% of disease-focused genomic studies are conducted ...
In private market investing, healthcare hasn't historically been the most enticing industry for individual investors. After all, compared to some other industries, healthcare has long ...
Nita Limdi, PharmD, Ph.D., MSPH, FAHA, has been named associate dean for Genomic Medicine, effective Oct. 1. After a national search process, Limdi assumed this role ...
More than 80 per cent of genomic studies across the world looking into diseases are concentrated in high-income countries, ...
Michael Murray, MD, has been named system chief of the division of genomic medicine and clinical director of the Institute for Genomic Health at New York City-based Mount Sinai. In this role, Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback